DOI Seite / Zitierlink:
https://doi.org/10.11588/diglit.3464#0381
Anti-Aging-Medizin auf dem Weg zur Wissenschaft 375
9. Kruse A (2002) Altern und Lebensqualität. In: Rabe T, Strowitzki T (Hrsg) Lifestyle und
Anti-Aging-Medizin. Baden-Baden: Rendezvous Verlag, 62-68
10. Schneider LA, Wlaschek M, Scharffetter-Kochanek K (2003) Hautalterung - Klinik und
Pathogenese. In: JDDG 3(i):223-233
11. Murakami S, Johnson TE (1996) A Genetic Pathway Conferring Life Extension and Resistance
to UV Stress in Caenorhabditis elegans. Genetics 143:1207-1218
12 Lamberts SWJ, van den Beld A.W, van der Lely A-J (1997) The Endocrinology of Aging.
Science 278:419-424
13. Nelson HD.Humphrey LL,Nygren P.Teutsch SM,Allan JD (2002) Postmenopausal Hormone
Replacement Therapy. JAMA 288:872-881
14. Rabe T, Bock K, Deckner C, Geisthövel F, Mueck AO (2004) Hormonersatztherapie - Nutzen
und Risiken. J Repromed Endokrinol 2:77-81
15. Rabe T, Mück AO, Hadji P, Geisthövel F, von Holst T (2005) Hormonersatztherapie. Nutzen
und Risiken. Gynäkologe 3:243-253
16. Wolf AS (2002) Altern und Hormone. In: Rabe T, Strowitzki T (Hrsg) Lifestyle und Anti-
Aging-Medizin. Baden-Baden: Rendezvous Verlag, 99-117
17. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel
M, Ernst M, Schulte HM, Allolio B. (1999) Dehydroepiandrosterone replacement in women
with adrenal insufficiency. N Engl J Med 34i(i4):ioi3-i020
18. Morales A, Nolan JJ, Nelson JC et al. (1994) Effects of replacement dose of dehydroepipan-
drosterone in men and women of advanced age. In: J Clin Endocrinol Metab 78:1360-1367
19. Baulieu EE (1996) Dehydroepiandrosterone sulfate does not predict cardiovascular death
in postmenopausal women. In: Circulation 91:1757-1760
20. Casson, PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE et al. (1995)
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in post-
menopausal women. Fertil Steril 63:1027-1031
21. Loria RM, Padgett DA, Huynh PN (1996) Regulation of the immune response by dehydro-
epiandrosterone and its metabolites. J Endocrinol 150:209-220
22. Suzuki T, Suzuki N, Daynes RA, Engelman EG (1991) Dehydroepiandrosterone enhaces IL-2
production and cy totoxic effector function of human T cells. Clin Immunol Immunopathol
61:202-211
23. Morales A, Haubrich RH, Hwang JY et al. (1998) The effect of the six month treatment with
a 100mg dose of dehydroepiandrosterone (DHEA) on circulating sex Steroids, body compo-
sition and muscle strength in age-advanced men and women. Clin Endocrinol 49:421-432
24. Yen SCC, Morales AJ, Khorram O (1995) Replacement of DHEA in aging men and women:
potential remedial effects. In: Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE
(eds) Dehydroepiandrosterone (DHEA) and aging. New York Academyof Science New York,
128-142
25. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L,
Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharriere O,
Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X,
Forette F (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution
of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sei 97(8):4279-84
26. Römmler A (2002) Die Adrenopause: Individuelle Substitution mit DHEA (Dehydroepi-
androsteron), 127-146. In: Rabe T, Strowitzki T (Hrsg) Lifestyle und Anti-Aging-Medizin.
Baden-Baden: Rendezvous Verlag
27. Cummings DE, Merriam GR (1999) Age related changes in growth hormone secretion:
should the somatopause be treated. Sem Reprod Endocrinol 17:311-325
28. Veldhuis JD, Iranmanesh A, Weltman A (1997) Elements in the pathophysiology of dimin-
ished growth hormone (GH) secretion in aging humans. Endocrinol 7:41-48
9. Kruse A (2002) Altern und Lebensqualität. In: Rabe T, Strowitzki T (Hrsg) Lifestyle und
Anti-Aging-Medizin. Baden-Baden: Rendezvous Verlag, 62-68
10. Schneider LA, Wlaschek M, Scharffetter-Kochanek K (2003) Hautalterung - Klinik und
Pathogenese. In: JDDG 3(i):223-233
11. Murakami S, Johnson TE (1996) A Genetic Pathway Conferring Life Extension and Resistance
to UV Stress in Caenorhabditis elegans. Genetics 143:1207-1218
12 Lamberts SWJ, van den Beld A.W, van der Lely A-J (1997) The Endocrinology of Aging.
Science 278:419-424
13. Nelson HD.Humphrey LL,Nygren P.Teutsch SM,Allan JD (2002) Postmenopausal Hormone
Replacement Therapy. JAMA 288:872-881
14. Rabe T, Bock K, Deckner C, Geisthövel F, Mueck AO (2004) Hormonersatztherapie - Nutzen
und Risiken. J Repromed Endokrinol 2:77-81
15. Rabe T, Mück AO, Hadji P, Geisthövel F, von Holst T (2005) Hormonersatztherapie. Nutzen
und Risiken. Gynäkologe 3:243-253
16. Wolf AS (2002) Altern und Hormone. In: Rabe T, Strowitzki T (Hrsg) Lifestyle und Anti-
Aging-Medizin. Baden-Baden: Rendezvous Verlag, 99-117
17. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel
M, Ernst M, Schulte HM, Allolio B. (1999) Dehydroepiandrosterone replacement in women
with adrenal insufficiency. N Engl J Med 34i(i4):ioi3-i020
18. Morales A, Nolan JJ, Nelson JC et al. (1994) Effects of replacement dose of dehydroepipan-
drosterone in men and women of advanced age. In: J Clin Endocrinol Metab 78:1360-1367
19. Baulieu EE (1996) Dehydroepiandrosterone sulfate does not predict cardiovascular death
in postmenopausal women. In: Circulation 91:1757-1760
20. Casson, PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE et al. (1995)
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in post-
menopausal women. Fertil Steril 63:1027-1031
21. Loria RM, Padgett DA, Huynh PN (1996) Regulation of the immune response by dehydro-
epiandrosterone and its metabolites. J Endocrinol 150:209-220
22. Suzuki T, Suzuki N, Daynes RA, Engelman EG (1991) Dehydroepiandrosterone enhaces IL-2
production and cy totoxic effector function of human T cells. Clin Immunol Immunopathol
61:202-211
23. Morales A, Haubrich RH, Hwang JY et al. (1998) The effect of the six month treatment with
a 100mg dose of dehydroepiandrosterone (DHEA) on circulating sex Steroids, body compo-
sition and muscle strength in age-advanced men and women. Clin Endocrinol 49:421-432
24. Yen SCC, Morales AJ, Khorram O (1995) Replacement of DHEA in aging men and women:
potential remedial effects. In: Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE
(eds) Dehydroepiandrosterone (DHEA) and aging. New York Academyof Science New York,
128-142
25. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L,
Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharriere O,
Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X,
Forette F (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution
of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sei 97(8):4279-84
26. Römmler A (2002) Die Adrenopause: Individuelle Substitution mit DHEA (Dehydroepi-
androsteron), 127-146. In: Rabe T, Strowitzki T (Hrsg) Lifestyle und Anti-Aging-Medizin.
Baden-Baden: Rendezvous Verlag
27. Cummings DE, Merriam GR (1999) Age related changes in growth hormone secretion:
should the somatopause be treated. Sem Reprod Endocrinol 17:311-325
28. Veldhuis JD, Iranmanesh A, Weltman A (1997) Elements in the pathophysiology of dimin-
ished growth hormone (GH) secretion in aging humans. Endocrinol 7:41-48